Bell Rock Capital’s Novo Nordisk NVO Stock Holding History

Bell Rock Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-32	Closed	–	–	434
2019 Q1	$0	Hold	32	–	–	﹤0.01%	453
2018 Q4	$0	Buy	+32	New	+$711	﹤0.01%	455

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bell Rock Capital's NVO Position: Q2 2019 in Review

Bell Rock Capital sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 32 shares.

Bell Rock Capital first reported a position in NVO in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

Bell Rock Capital reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
Bell Rock Capital sold 32 Novo Nordisk shares in Q2 2019.
Bell Rock Capital first reported a position in Novo Nordisk in Q4 2018 and held it in 2 quarters.
Bell Rock Capital's Novo Nordisk position peaked at $0 in Q1 2019.
559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Bell Rock Capital's 13F filing for Q2 2019, filed 31 Jul 2019.